NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding NeuroPace Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 40 | 1 | 32 | −7 |
| Shares | 18.2M | 1.16K | 18.4M | +217.2K (+1.2%) |
| Value | $149.5M | $9.00K | $91.2M | −$58.3M (−39.0%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held NeuroPace Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Opaleye Management Inc. | 90,100 | $446.0K | 0.20% |
| Ergoteles LLC | 34,800 | $172.0K | 0.01% |
| Bridgeway Capital Management, LLC | 26,148 | $129.0K | 0.00% |
| Citadel Advisors LLC | 21,692 | $108.0K | 0.00% |
| Renaissance Technologies LLC | 12,700 | $63.0K | 0.00% |
| Nisa Investment Advisors, LLC | 3,000 | $15.0K | 0.00% |
| Credit Suisse AG | 4 | $0 | 0.00% |
| Ellevest, Inc. | 6 | $0 | 0.00% |
Sold out (15)
Institutions that held NeuroPace Inc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Kornitzer Capital Management Inc | 199,919 | $1.64M |
| Norges Bank | 58,000 | $476.2K |
| Nuveen Asset Management, LLC | 17,850 | $150.0K |
| Bank of New York Mellon Corp | 17,875 | $147.0K |
| Charles Schwab Investment Management Inc | 16,968 | $140.0K |
| Deutsche Bank AG | 3,857 | $32.0K |
| American International Group, Inc. | 3,525 | $29.0K |
| JPMorgan Chase & Co | 3,330 | $27.0K |
| California State Teachers Retirement System | 3,025 | $25.0K |
| Tower Research Capital LLC (TRC) | 1,632 | $13.0K |
| Amalgamated Bank | 1,156 | $9.00K |
| Legal & General Group Plc | 730 | $6.00K |
| Ameritas Investment Partners, Inc. | 546 | $4.00K |
| UBS Group AG | 101 | $1.00K |
| Capital Advisors, Ltd. LLC | 41 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held NeuroPace Inc at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 1,156 | $9.00K |